Brief: Karyopharm Therapeutics Q1 Net Income USD -23.462 Million
May 12 (Reuters) - Karyopharm Therapeutics Q1 product revenue USD 21.054 million. Q1 operating expenses USD 63.271 million Q1 operating income USD -33.256 million outlook FY revenue USD 140-155 million